Literature DB >> 26364287

Protection and Repair After Spinal Cord Injury: Accomplishments and Future Directions.

W Dalton Dietrich1.   

Abstract

It was an honor for me to present the 2014 G. Heiner Sell Memorial Lecture at the annual American Spinal Injury Association (ASIA) meeting in San Antonio. For this purpose, I provided a comprehensive review of the scope of research targeting discovery and translational and clinical investigations into spinal cord injury (SCI) research. Indeed, these are exciting times in the area of spinal cord research and clinical initiatives. Many laboratories and clinical programs throughout the world are publishing data related to the pathophysiology of SCI and new strategies for protecting and promoting recovery in both animal models and humans. For this lecture, several topics were discussed including neuroprotective and reparative strategies, neurorehabilitation, quality of life issues, and future directions. In the area of neuroprotection, pathophysiological events that may be targeted with therapeutic strategies, including pharmacological and targeted temperature management were reviewed. For reparative approaches, the importance of both intrinsic and extrinsic mechanisms of axonal regeneration was highlighted. Various cell therapies currently being tested in preclinical and clinical arenas were reviewed as well as ongoing US Food and Drug Administration approved trials for SCI patients. Neurorehabilitation is an evolving research field with locomotive training strategies, electrical stimulation, and brain-machine interface programs targeting various types of SCI. The importance of testing combination approaches including neuroprotective, reparative, and rehabilitative strategies to maximize recovery mechanisms was therefore emphasized. Finally, quality of life issues that affect thousands of individuals living with paralysis were also presented. Future directions and specific obstacles that require attention as we continue to move the SCI field forward were discussed.

Entities:  

Mesh:

Year:  2015        PMID: 26364287      PMCID: PMC4568099          DOI: 10.1310/sci2102-174

Source DB:  PubMed          Journal:  Top Spinal Cord Inj Rehabil        ISSN: 1082-0744


  114 in total

1.  Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury.

Authors:  Yaniv Ziv; Hila Avidan; Stefano Pluchino; Gianvito Martino; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-22       Impact factor: 11.205

Review 2.  Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations.

Authors:  Charles H Tator
Journal:  Neurosurgery       Date:  2006-11       Impact factor: 4.654

3.  The impact of spinal cord injury on sexual function: concerns of the general population.

Authors:  K D Anderson; J F Borisoff; R D Johnson; S A Stiens; S L Elliott
Journal:  Spinal Cord       Date:  2006-10-10       Impact factor: 2.772

Review 4.  Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey?

Authors:  M Wyndaele; J-J Wyndaele
Journal:  Spinal Cord       Date:  2006-01-03       Impact factor: 2.772

5.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

6.  A molecular platform in neurons regulates inflammation after spinal cord injury.

Authors:  Juan Pablo de Rivero Vaccari; George Lotocki; Alex E Marcillo; W Dalton Dietrich; Robert W Keane
Journal:  J Neurosci       Date:  2008-03-26       Impact factor: 6.167

7.  A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model.

Authors:  Alberto Pinzon; Alexander Marcillo; Ada Quintana; Sarah Stamler; Mary Bartlett Bunge; Helen M Bramlett; W Dalton Dietrich
Journal:  Brain Res       Date:  2008-09-24       Impact factor: 3.252

8.  Microglia inhibition is a target of mild hypothermic treatment after the spinal cord injury.

Authors:  T Morino; T Ogata; J Takeba; H Yamamoto
Journal:  Spinal Cord       Date:  2008-03-04       Impact factor: 2.772

9.  Hypothermia for spinal cord injury.

Authors:  Brian K Kwon; Cody Mann; Hong Moon Sohn; Alan S Hilibrand; Frank M Phillips; Jeffrey C Wang; Michael G Fehlings
Journal:  Spine J       Date:  2008-03-10       Impact factor: 4.166

Review 10.  Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials.

Authors:  J W Fawcett; A Curt; J D Steeves; W P Coleman; M H Tuszynski; D Lammertse; P F Bartlett; A R Blight; V Dietz; J Ditunno; B H Dobkin; L A Havton; P H Ellaway; M G Fehlings; A Privat; R Grossman; J D Guest; N Kleitman; M Nakamura; M Gaviria; D Short
Journal:  Spinal Cord       Date:  2006-12-19       Impact factor: 2.772

View more
  2 in total

1.  Restoration of hand function with long-term paired associative stimulation after chronic incomplete tetraplegia: a case study.

Authors:  A Rodionov; S Savolainen; E Kirveskari; J P Mäkelä; A Shulga
Journal:  Spinal Cord Ser Cases       Date:  2019-10-01

2.  A Subdural Bioelectronic Implant to Record Electrical Activity from the Spinal Cord in Freely Moving Rats.

Authors:  Bruce Harland; Zaid Aqrawe; Maria Vomero; Christian Boehler; Ernest Cheah; Brad Raos; Maria Asplund; Simon J O'Carroll; Darren Svirskis
Journal:  Adv Sci (Weinh)       Date:  2022-05-02       Impact factor: 17.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.